Dr. Lam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2700 Stockton Blvd
Sacramento, CA 95817Phone+1 916-734-0910Fax+1 916-734-7946
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1987 - 1989
- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1984 - 1987
- Stanford University School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 1999 - 2021
Publications & Presentations
PubMed
- 66 citationsThe NIH Somatic Cell Genome Editing programKrishanu Saha, Erik J. Sontheimer, P. J. Brooks, Melinda R. Dwinell, Charles A. Gersbach
Nature. 2021-04-07 - 84 citationsDual blockade of CD47 and HER2 eliminates radioresistant breast cancer cellsDemet Candas-Green, Bowen Xie, Jie Huang, Ming Fan, Aijun Wang
Nature Communications. 2020-09-14 - 116 citationsTransformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivoLu Zhang, Di Jing, Nian Jiang, Tatu Rojalin, Christopher M. Baehr
Nature Nanotechnology. 2020-01-27
Press Mentions
- New Center for Experimental Therapeutics in Cancer Advances Promising TreatmentsOctober 7th, 2022
- Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide SynthesisMarch 26th, 2024
Grant Support
- Discovery Of Ligands For Directed-Differentiation Of Stem CellsNational Heart, Lung, And Blood Institute2012
- Multi-Functional Nanocarrier Against Canine LymphomaNational Institute Of Biomedical Imaging And Bioengineering2011–2012
- Therapeutic Targeting Agents For Ovarian CancerNational Cancer Institute2005–2012
- High Affinity Capturing Agents For StrychnineNational Institute Of Neurological Disorders And Stroke2010–2011
- Feasibility Of Nanoparticle-Mediated Paclitaxel DeliveryNational Center For Research Resources2010–2011
- Dna-Modulated Release Of Drug From Melanoma Targeting NPNational Cancer Institute2008–2009
- Optimization And Characterization Of Targeting Agents For Lymphoid MalignanciesNational Cancer Institute2007–2009
- High Affinity Ligand To Deliver Nanoparticle Drugs To Lymphoid CancersNational Cancer Institute2007–2009
- Targeting Agents For Human And Canine LymphomaNational Cancer Institute2005–2009
- C-SRC Inhibitors From Novel Encoded Chemical LibrariesNational Cancer Institute2003–2007
- Optimization And Characterization Of Targeting AgentsNational Cancer Institute2005–2006
- Combinatorial Peptide Libraries For Biodegradable Linkers To Decrease Normal TissNational Cancer Institute2004–2006
- Administrative CoreNational Cancer Institute2005
- Protein Kinase Specific PET Imaging Agent For CancerNational Cancer Institute2004–2005
- Small Molecule Microarrays For Intracellular ProteinsNational Cancer Institute2003–2005
- UC Davis AP4 CenterNational Cancer Institute2004
- Peptide Microarray For Cancer Cell Surface ReceptorsNational Institute Of Biomedical Imaging And Bioengineering2003
- Peptide Microarray For Cancer Cell Surface ReceptorsNational Cancer Institute2001–2002
- Ligands For Altered Phosphoproteins In CancerNational Cancer Institute2000–2002
- Peptide Substrate For Unique Protein Kinase In TissueNational Cancer Institute1999–2000
- Novel Antibiotics For Vancomycin Resistant InfectionNational Institute Of Allergy And Infectious Diseases1999
- Peptide Ligand For Altered Protein In Disease TissuesNational Cancer Institute1999
- Identification Of Small Molecule Inhibitors Of Protein Tyrosine KinaseNational Center For Research Resources1998–1999
- Peptide Substrate For Unique Protein Kinase In TissueNational Cancer Institute1998
- Peptide Ligand For Altered Protein In Disease TissuesNational Cancer Institute1998
- Novel Antibiotics For Vancomycin Resistant InfectionNational Institute Of Allergy And Infectious Diseases1997–1998
- Molecular Screening Of Cancer-Associated ReceptorsNational Cancer Institute1992–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: